US Markets for Nonvascular Stents
This article was originally published in Start Up
Executive Summary
Lately, drug-eluting stents have downright monopolized all discussions of new stent technology, but there's a whole world of stenting outside of the interventional cardiology suite, and some of these clinical applications represent healthy markets for small companies. According to a report published in June by the Medtech Insight division of Windhover Information, "US Markets for Nonvascular Stents," sales of stents in several non-cardiology niche markets totaled approximately $152 million in 2005, a year in which stents were used in approximately 491,000 nonvascular endoluminal recanalization procedures. Overall, sales of these products are expected to grow at an annual compound rate of almost 3%, reaching approximately $174 million in the year 2010.